Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Genta Incorporated.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Genta Incorporated
ClinicalTrials.gov Identifier:
NCT01296243
First received: February 10, 2011
Last updated: July 20, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)